Seeking Alpha

hoopdreamerz@yahoo.com » Comments » Single Comment |

  • ImClone: Non-Justifiable Scientific Downgrades Refuted  [View article]
    I definitely agree with your sentiments.

    Only thing to point out, your %'s cited here are wrong. Its 48% vs 52%, not 43 and 61%.

    <<Following a median of four treatment cycles, response rates were 43% (21/44) in the chemotherapy alone arm and 61% (23/44) in the combination ERBITUX and chemotherapy arm.>>
    Aug 07 09:44 am |Rating: 0 0
All Comments by hoopdreamerz@yahoo.com »
Comments by Ticker
hoopdreamerz@yahoo.com's
Comments Stats
97 comments
Rating: 2 (77 - 75 )